Medtronic plc announced the appointment of Chad Spooner as chief financial officer (CFO) of MiniMed, the name for its planned standalone diabetes company. This appointment is effective July 14, 2025, and is a key step in preparing for the intended separation.
Spooner will be responsible for overseeing the Finance function for Medtronic Diabetes and supporting initiatives aimed at accelerating profitable growth and delivering shareholder value as it prepares to become fully independent. He brings over 25 years of financial leadership experience across healthcare, consumer, and industrial sectors.
This executive appointment underscores Medtronic's commitment to building a strong foundation for MiniMed's long-term success as an independent entity. The separation is targeted for completion within 18 months of the initial announcement, subject to customary conditions.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.